Market Movers

The Clorox Company’s Stock Price Plummets to $148.21, Witnessing a Sharp 7.24% Decline

By February 5, 2025 No Comments

The Clorox Company (CLX)

148.21 USD -11.57 (-7.24%) Volume: 4.66M

“The Clorox Company’s stock price stands at 148.21 USD, experiencing a significant drop of 7.24% this trading session, with a trading volume reaching 4.66M. With a year-to-date percentage change of -8.74%, CLX’s performance continues to draw investor attention.”


Latest developments on The Clorox Company

Clorox Company (NYSE:CLX) has been making headlines recently with its impressive Q2 earnings report, beating revenue expectations and raising guidance for the fiscal year 2025. Despite facing some challenges, such as a drop in sales and cautious outlook, the company remains confident in its growth prospects. Clorox defended its $580M digital transformation efforts and announced strategic updates to address weakening business categories. Analysts have responded positively to the upbeat earnings, boosting their forecasts and raising the price target for CLX shares. With the stock price movements reflecting these developments, shareholders have earned a 7.4% CAGR over the last three years. The company’s proactive approach and strong performance indicate a promising future ahead.


The Clorox Company on Smartkarma

Analysts on Smartkarma, like Baptista Research, have been covering the Clorox Company and providing valuable insights. In their report “The Clorox Company: Its Enhanced Focus On High Margin Products As A Vital Tool For Growth! – Major Drivers,” they highlighted the company’s robust first-quarter performance for fiscal year 2025. CEO Linda Rendle emphasized the recovery from a cyber attack in August 2023 and the significant advancements in market share restoration and gross margin expansion. Strategic investments in marketing and innovation were credited for the company’s success in expanding its market share across multiple categories.

In another report, “The Clorox Company: A Dive Into Its Market Positioning,” Baptista Research delved into the company’s fiscal year 2024 fourth-quarter earnings. Despite operational challenges, including a cyberattack, Clorox ended the fiscal year on a stable note with flat organic sales year-over-year. The report highlighted a recovery in subsequent quarters following an initial decline due to the cyber incident. Baptista Research also aimed to evaluate factors influencing the company’s price in the future and conducted an independent valuation using a Discounted Cash Flow (DCF) methodology.


A look at The Clorox Company Smart Scores

FactorScoreMagnitude
Value2
Dividend4
Growth3
Resilience2
Momentum4
OVERALL SMART SCORE3.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Clorox Company has a mixed long-term outlook. While the company scores well in areas such as Dividend and Momentum, it falls short in Value and Resilience. With a score of 4 for Dividend and Momentum, Clorox Company shows strength in its ability to provide returns to investors and maintain positive market momentum. However, with lower scores in Value and Resilience, the company may face challenges in terms of its overall financial health and ability to weather economic uncertainties.

The Clorox Company, known for its household cleaning and bleach products, faces a somewhat uncertain future according to the Smartkarma Smart Scores. While the company demonstrates strong momentum and a solid dividend track record, its value and resilience scores are less impressive. As Clorox continues to market its products both domestically and internationally, investors may want to keep a close eye on how the company navigates these challenges to ensure long-term success.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars